Ypsomed is now able to conduct 50% more transactions with the same number of employees – thanks to E2E Commerce


About Ypsomed

Ypsomed is a worldwide leading independent developer and manufacturer of custom-made self-administration injection systems and the supplier of pen needles for the treatment of diabetes, growth disorders or infertility, as well as for other therapeutic areas. Ypsomed has well-established partnerships with numerous leading pharmaceutical and biotech companies such as Sanofi, Eli Lilly, Pfizer, Roche, Genentech, Merck Serono, Amylin, NPS and others. Ypsomed is headquartered in Burgdorf, Switzerland, and employs approximately 1,050 employees at several production sites in Switzerland and throughout a European sales and distribution network.

The E2E Bridge is the organic glue which integrates our processes with the central SAP system. Its lean and transparent approach keeps all stakeholders involved.

– Fernand Portenier, Informatikleiter, Ypsomed



  • Existing e-Shop not integrated with SAP ERP
  • SAP NetWeaver PI not suitable for an agile approach
  • Integration with third party apps challenging


  • Flexible glueware approach to process integration
  • ONE integration platform for up to 50 interfaces
  • Lightweight, rapid + incremental lifecycle


  • Lean, cost-effective process integration
  • Close collaboration between business and IT
  • Single source of truth with direct model execution
  • 50% more orders processed with same staff numbers
  • Effective accommodation of US FDA audit
  • Process template for multi-country roll-out